In 2022, Kevin Conroy earned $6.16M in total compensation at Exact Sciences, including $1.00M salary, $749.25K bonus and $4.13M in stock. Most recently sold 1,155 shares in Apr 2024. Currently holds stock worth $123.87M. Has donated $18.83M in stock to charitable causes. Led Exact Sciences as CEO for 8 years.
Compensation History
Annual executive compensation data for Kevin Conroy, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$6.16M
Salary
$1.00M
Bonus
$749.25K
Other
$279.42K
Salary
$1.00MBoard Justification
The compensation program is designed to attract, motivate, and retain executive officers, with a significant portion of compensation being performance-based and aligned with shareholder interests.
Bonus
$749.25KBoard Justification
In 2022, Mr. Conroy received a cash bonus of $749,245 based on the achievement of corporate goals established for the annual cash bonus plan.
Other Compensation
$279.42KBoard Justification
Other compensation includes a matching contribution to the 401(k) plan, reimbursement for business expenses, and travel expenses paid by the Company.
Restricted Stock
Board Justification
In 2022, Mr. Conroy received 52,722 RSUs that vested in eleven equal monthly installments from February 2022 through December 2022, as part of his base salary compensation.
Performance Metrics
The performance metrics for 2022 included revenue growth, achievement of corporate goals, and overall company performance.
Kevin Conroy
Ex-CEO of Exact Sciences
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of Exact Sciences for
8 years 5 months (Jul 2014 - Dec 2022)
Previous Experience
President and Chief Executive Officer at Exact Sciences Corporation, various leadership roles at Exact Sciences Corporation
Holdings
Track Kevin Conroy's stock holdings and portfolio value over time.
Total Stock Sold
$172.69M
$172.69M
3,161,913 EXAS shares
What if they kept their stock?
If Kevin Conroy didn't sell their stock, today they would have:
Extra EXAS3,161,913 shares worth $319.54M.
This is 85.04% and $146.85M more than what they got when they sold the stock.
Charitable Transactions
186,304 shares
EXAS
Recent Charitable Transactions
35,750 shares
EXAS
Feb 1, 2021
Charity
65,189 shares
EXAS
Dec 31, 2019
Charity
2,522 shares
EXAS
Dec 31, 2015
Charity
68,332 shares
EXAS
Dec 31, 2014
Charity
4,092 shares
EXAS
Dec 31, 2013
Charity
1,500 shares
EXAS
Dec 26, 2012
Charity
Insider Trading
Kevin Conroy's recent stock transactions, purchases, and sales filed with the SEC.
$69.47K
EXAS at $60.15/share
Apr 30, 2024
Sale
$47.99K
EXAS at $15.01/share
Apr 30, 2024
Received
$490.64K
EXAS at $59.32/share
Feb 29, 2024
Sale
$356.30K
EXAS at $56.89/share
Feb 26, 2024
Sale
$691.36K
EXAS at $59.78/share
Feb 21, 2024
Sale
23,238 shares
EXAS
Feb 21, 2024
Received
$305.96K
EXAS at $61.50/share
Feb 20, 2024
Sale
$908.61K
EXAS at $61.43/share
Feb 14, 2024
Sale
$21.28K
EXAS at $30.02/share
Feb 14, 2024
Received
Rivals
Compare Kevin Conroy with competitor CEOs and industry peers.